Search

We ask an expert for their top tips for ensuring outsourcing goes smoothly.

How fucosylation-deficient CHO cell hosts can help enhance the potency of monoclonal antibody-based biotherapeutics

In this webinar, Matthew Schiesher from Cambrex delves deeper into this process, enlightening attendees on the optimal ways to guide projects from conception to completion, and how to incorporate design of experiments to set critical process parameters and proven acceptable ranges.

When it comes to influenza, chicken egg-based vaccines have achieved much, but emerging approaches are ready to fly the coop.

What can science learn from patients, and how can patients benefit from being in control of their own health?

Three experts give their views on the state of play in cell and gene manufacturing, and the challenges that lie ahead

Will next gen antibodies knock our socks off? Experts consider the future of antibody-based drug development

What lies ahead for antibody discovery? We ask experts from RQ Bio.

Patient-centricity needs to be more than a buzzword. Here’s how Boehringer Ingelheim is weaving it into its culture.

High growth predictions for regenerative medicine are exciting, but what if current capacity can’t keep pace?